发明公开
- 专利标题： DRUG METABOLIZING ENZYMES
- 专利标题（中）： 药物代谢酶
-
申请号： EP02740014.2申请日： 2002-07-05
-
公开(公告)号： EP1572877A2公开(公告)日： 2005-09-14
- 发明人: GRIFFIN, Jennifer, A. , RAMKUMAR, Jayalaxmi , EMERLING, Brooke, M. , RICHARDSON, Thomas, W. , LI, Joana, X. , WARREN, Bridget, A. , HONCHELL, Cynthia, D. , BAUGHN, Mariah, R. , TANG, Y., Tom , LEE, Ernestine, A. , ELLIOTT, Vicki, S. , YUE, Henry , LEE, Sally , SWARNAKAR, Anita , FORSYTHE, Ian, J. , SANJANWALA, Madhusudan, M. , YAO, Monique, G. , ZEBARJADIAN, Yeganeh , GORVAD, Ann, E. , BECHA, Shanya
- 申请人： Incyte Genomics, Inc.
- 申请人地址： 3160 Porter Drive Palo Alto, CA 94304 US
- 专利权人： Incyte Genomics, Inc.
- 当前专利权人： Incyte Genomics, Inc.
- 当前专利权人地址： 3160 Porter Drive Palo Alto, CA 94304 US
- 代理机构： Wright, Simon Mark
- 优先权： US303745P 20010706; US305402P 20010713; US308158P 20010727; US322127P 20010914
- 国际公布： WO2003004608 20030116
- 主分类号： C12N1/00
- IPC分类号： C12N1/00
摘要：
Various embodiments of the invention provide human drug metabolizing enzymes (DME) and polynucleotides which identify and encode DME. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of DME.
公开/授权文献
- EP1572877A3 DRUG METABOLIZING ENZYMES 公开/授权日：2005-10-05
信息查询
